RT Journal Article
T1 Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report.
A1 Cingi, C
A1 Gevaert, P
A1 Mösges, R
A1 Rondon, C
A1 Hox, V
A1 Rudenko, M
A1 Muluk, N B
A1 Scadding, G
A1 Manole, F
A1 Hupin, C
A1 Fokkens, W J
A1 Akdis, C
A1 Bachert, C
A1 Demoly, P
A1 Mullol, J
A1 Muraro, A
A1 Papadopoulos, N
A1 Pawankar, R
A1 Rombaux, P
A1 Toskala, E
A1 Kalogjera, L
A1 Prokopakis, E
A1 Hellings, P W
A1 Bousquet, J
K1 Adenoid hypertrophy
K1 Allergic rhinitis (AR)
K1 Asthma
K1 Chronic middle ear effusions
K1 Comorbidities
K1 Conjunctivitis
K1 Disordered sleep
K1 Eczema
K1 Eosinophilic oesophagitis (EoE)
K1 Food allergies
K1 Obstructive sleep apnea
K1 Olfaction disorders
K1 Rhinitis
K1 Rhinosinusitis
AB This report has been prepared by the European Academy of Allergy and Clinical Immunology Task Force on Allergic Rhinitis (AR) comorbidities. The aim of this multidisciplinary European consensus document is to highlight the role of multimorbidities in the definition, classification, mechanisms, recommendations for diagnosis and treatment of AR, and to define the needs in this neglected area by a literature review. AR is a systemic allergic disease and is generally associated with numerous multi-morbid disorders, including asthma, eczema, food allergies, eosinophilic oesophagitis (EoE), conjunctivitis, chronic middle ear effusions, rhinosinusitis, adenoid hypertrophy, olfaction disorders, obstructive sleep apnea, disordered sleep and consequent behavioural and educational effects. This report provides up-to-date usable information to: (1) improve the knowledge and skills of allergists, so as to ultimately improve the overall quality of patient care; (2) to increase interest in this area; and (3) to present a unique contribution to the field of upper inflammatory disease.
SN 2045-7022
YR 2017
FD 2017-06-01
LK http://hdl.handle.net/10668/11260
UL http://hdl.handle.net/10668/11260
LA en
DS RISalud
RD Apr 8, 2025